Pharma Journalist -

ESSA Pharma, a clinical-stage pharmaceutical company focused on the development of novel small molecule drugs for the treatment of prostate cancer, announced that early data from the…
Read More...

Kamada, a plasma-derived protein therapeutics company focused on orphan indications, announced the appointment of Michal Stein, M.D., as Vice President and Medical Director for…
Read More...

BioCryst Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for a pediatric indication of…
Read More...

Cornerstone Pharmaceuticals announced that it is changing its corporate name to Rafael Pharmaceuticals effective immediately. The name change signifies a new era in the company’s…
Read More...

Aequus Pharmaceuticals and the Centre For Drug Research and Development (CDRD) announced a broad research collaboration to establish pre-clinical safety and efficacy of select…
Read More...

Jazz Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with Priority Review its recently submitted New Drug Application (NDA) for  …
Read More...

The pharmaceutical Company Sylentis (PharmaMar Group) has announced the start of the first Phase III study, HELIX, with the investigational new drug, SYL1001 for the indication of dry…
Read More...

Nutriceutical Holdings (NH), parent company of Physician Recommended Nutriceuticals (PRN) and Veterinarian Recommended Solutions (VRS), and KD Pharma Group have decided to join forces…
Read More...

OBI Pharma announced an agreement with Threshold Pharmaceuticals, Inc. to acquire TH-3424, a first-in-class novel small-molecule prodrug that selectively targets cancers overexpressing…
Read More...

BioCryst Pharmaceuticals announced results from a second interim analysis of its Phase 2 APeX-1 clinical trial in hereditary angioedema (HAE). APeX-1 is a 3-part dose ranging trial…
Read More...